Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group, „The Lancet”, 352 (9131), 1998, s. 854–865, DOI: 10.1016/S0140-6736(98)07037-8, PMID: 9742977(ang.).
MarzenaM.GrzybowskaMarzenaM., JoannaJ.BoberJoannaJ., MariaM.OlszewskaMariaM., Metformina – mechanizmy działania i zastosowanie w terapii cukrzycy typu 2, „Postępy Higieny i Medycyny Doświadczalnej”, 65, 2011, s. 277–285, DOI: 10.5604/17322693.941655.
AlejandroA.Martin-MontalvoAlejandroA. i inni, Metformin improves healthspan and lifespan in mice, „Nature Communications”, 4, 2013, DOI: 10.1038/ncomms3192, PMID: 23900241, PMCID: PMC3736576(ang.).
LucydalilaL.CedilloLucydalilaL. i inni, Ether lipid biosynthesis promotes lifespan extension and enables diverse pro-longevity paradigms in Caenorhabditis elegans, „eLife”, 12, 2023, DOI: 10.7554/eLife.82210, PMID: 37606250, PMCID: PMC10444025 [dostęp 2024-01-24](ang.).
AnnaA.MarkowskaAnnaA. i inni, Could there be a role for the antidiabetic drug metformin in oncological treatment?, „European Journal of Gynecological Oncology”, 39 (6), 2018, s. 867–870, DOI: 10.12892/ejgo4677.2018(ang.).
Heather A.H.A.HirschHeather A.H.A. i inni, Metformin selectively targets cancer stem cells, and acts together with chemotherapy to block tumor growth and prolong remission, „Cancer Research”, 69 (19), 2009, s. 7507–7511, DOI: 10.1158/0008-5472.CAN-09-2994, PMID: 19752085, PMCID: PMC2756324(ang.).
Gijs W.D.G.W.D.LandmanGijs W.D.G.W.D. i inni, Metformin associated with lower cancer mortality in type 2 diabetes: ZODIAC-16, „Diabetes Care”, 33 (2), 2010, s. 322–326, DOI: 10.2337/dc09-1380, PMID: 19918015, PMCID: PMC2809274(ang.).
Jared M.J.M.CampbellJared M.J.M. i inni, Metformin reduces all-cause mortality and diseases of ageing independent of its effect on diabetes control: A systematic review and meta-analysis, „Ageing Research Reviews”, 40, 2017, s. 31–44, DOI: 10.1016/j.arr.2017.08.003(ang.).
JamesJ.McCormackJamesJ., KevinK.JohnsKevinK., HughH.TildesleyHughH., Metformin’s contraindications should be contraindicated, „Canadian Medical Association Journal”, 173 (5), 2005, s. 502–504, DOI: 10.1503/cmaj.045292, PMID: 16129871, PMCID: PMC1188187(ang.).
A.A.HolsteinA.A., M.M.StumvollM.M., Contraindications can damage your health-is metformin a case in point?, „Diabetologia”, 48 (12), 2005, s. 2454–5459, DOI: 10.1007/s00125-005-0026-1, PMID: 16283245(ang.).
Jolien deJ.JagerJolien deJ. i inni, Long term treatment with metformin in patients with type 2 diabetes and risk of vitamin B-12 deficiency: randomised placebo controlled trial, „British Medical Journal”, 340, 2010, c2181, DOI: 10.1136/bmj.c2181, PMID: 20488910, PMCID: PMC2874129(ang.).
Metformina, [w:] Indeks Leków MP, opis substancji, Medycyna Praktyczna.
nih.gov
ncbi.nlm.nih.gov
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group, „The Lancet”, 352 (9131), 1998, s. 854–865, DOI: 10.1016/S0140-6736(98)07037-8, PMID: 9742977(ang.).
AlejandroA.Martin-MontalvoAlejandroA. i inni, Metformin improves healthspan and lifespan in mice, „Nature Communications”, 4, 2013, DOI: 10.1038/ncomms3192, PMID: 23900241, PMCID: PMC3736576(ang.).
LucydalilaL.CedilloLucydalilaL. i inni, Ether lipid biosynthesis promotes lifespan extension and enables diverse pro-longevity paradigms in Caenorhabditis elegans, „eLife”, 12, 2023, DOI: 10.7554/eLife.82210, PMID: 37606250, PMCID: PMC10444025 [dostęp 2024-01-24](ang.).
Heather A.H.A.HirschHeather A.H.A. i inni, Metformin selectively targets cancer stem cells, and acts together with chemotherapy to block tumor growth and prolong remission, „Cancer Research”, 69 (19), 2009, s. 7507–7511, DOI: 10.1158/0008-5472.CAN-09-2994, PMID: 19752085, PMCID: PMC2756324(ang.).
Gijs W.D.G.W.D.LandmanGijs W.D.G.W.D. i inni, Metformin associated with lower cancer mortality in type 2 diabetes: ZODIAC-16, „Diabetes Care”, 33 (2), 2010, s. 322–326, DOI: 10.2337/dc09-1380, PMID: 19918015, PMCID: PMC2809274(ang.).
JamesJ.McCormackJamesJ., KevinK.JohnsKevinK., HughH.TildesleyHughH., Metformin’s contraindications should be contraindicated, „Canadian Medical Association Journal”, 173 (5), 2005, s. 502–504, DOI: 10.1503/cmaj.045292, PMID: 16129871, PMCID: PMC1188187(ang.).
A.A.HolsteinA.A., M.M.StumvollM.M., Contraindications can damage your health-is metformin a case in point?, „Diabetologia”, 48 (12), 2005, s. 2454–5459, DOI: 10.1007/s00125-005-0026-1, PMID: 16283245(ang.).
Jolien deJ.JagerJolien deJ. i inni, Long term treatment with metformin in patients with type 2 diabetes and risk of vitamin B-12 deficiency: randomised placebo controlled trial, „British Medical Journal”, 340, 2010, c2181, DOI: 10.1136/bmj.c2181, PMID: 20488910, PMCID: PMC2874129(ang.).